Adrenal insufficiency resident survival guide: Difference between revisions
(→Do's) |
No edit summary |
||
(4 intermediate revisions by one other user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{WikiDoc CMG}}; {{AE}} | {{WikiDoc CMG}}; {{AE}} {{Ayeesha}} | ||
==Overview== | ==Overview== | ||
[[Adrenal insufficiency]] is a clinical state where there is reduced production of adrenocortical hormones. The [[adrenal cortex]] is divided into three zones- [[zona glomerulosa]], [[zona fasciculata]] and [[zona reticularis]] producing [[mineralocorticoids]], [[glucocorticoids]] and [[androgens]] respectively. [[Adrenal insufficiency]] can cause [[glucocorticoid]] and [[mineralocorticoid]] deficiency. It is classified as primary, secondary and tertiary. | [[Adrenal insufficiency]] is a clinical state where there is reduced production of adrenocortical hormones. The [[adrenal cortex]] is divided into three zones- [[zona glomerulosa]], [[zona fasciculata]] and [[zona reticularis]] producing [[mineralocorticoids]], [[glucocorticoids]] and [[androgens]] respectively. [[Adrenal insufficiency]] can cause [[glucocorticoid]] and [[mineralocorticoid]] deficiency. It is classified as primary, secondary and tertiary. Its presentation depends on the rapidity and degree of hormone depletion. It can present acutely as [[adrenal crisis]], especially when the body is under stress due [[infections]], trauma etc. If it presents chronically, it is called [[Addison's disease]]. The common causes include chronic [[glucocorticoid]] use and autoimmune adrenalitis. It is diagnosed using serum basal [[cortisol]] measurement and [[ACTH]] stimulation test. Treatment consists of lifelong [[glucocorticoid]] and [[mineralocorticoid]] replacement. <ref>{{cite journal |vauthors=Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dungan K, Grossman A, Hershman JM, Hofland J, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Purnell J, Singer F, Stratakis CA, Trence DL, Wilson DP, Nicolaides NC, Chrousos GP, Charmandari E |title= |journal= |volume= |issue= |pages= |date= |pmid=25905309 |doi= |url=}}</ref> <ref>{{cite journal |vauthors=Huecker MR, Dominique E |title= |journal= |volume= |issue= |pages= |date= |pmid=28722862 |doi= |url=}}</ref> | ||
==Causes== | ==Causes== | ||
===Life Threatening Causes=== | ===Life-Threatening Causes=== | ||
Life-threatening causes include conditions that may result in death or permanent disability within 24 hours if left untreated.<ref>https://www.ncbi.nlm.nih.gov/books/NBK499968/</ref> | Life-threatening causes include conditions that may result in death or permanent disability within 24 hours if left untreated.<ref>https://www.ncbi.nlm.nih.gov/books/NBK499968/</ref> | ||
Line 60: | Line 60: | ||
==Treatment== | ==Treatment== | ||
Shown below is an algorithm summarizing the treatment of [[adrenal insufficiency]]. <ref name="BornsteinAllolio2016">{{cite journal|last1=Bornstein|first1=Stefan R.|last2=Allolio|first2=Bruno|last3=Arlt|first3=Wiebke|last4=Barthel|first4=Andreas|last5=Don-Wauchope|first5=Andrew|last6=Hammer|first6=Gary D.|last7=Husebye|first7=Eystein S.|last8=Merke|first8=Deborah P.|last9=Murad|first9=M. Hassan|last10=Stratakis|first10=Constantine A.|last11=Torpy|first11=David J.|title=Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline|journal=The Journal of Clinical Endocrinology & Metabolism|volume=101|issue=2|year=2016|pages=364–389|issn=0021-972X|doi=10.1210/jc.2015-1710}}</ref> <ref name="OpreaBonnet2019">{{cite journal|last1=Oprea|first1=Alina|last2=Bonnet|first2=Nicolas C. G.|last3=Pollé|first3=Olivier|last4=Lysy|first4=Philippe A.|title=Novel insights into glucocorticoid replacement therapy for pediatric and adult adrenal insufficiency|journal=Therapeutic Advances in Endocrinology and Metabolism|volume=10|year=2019|pages=204201881882129|issn=2042-0188|doi=10.1177/2042018818821294}}</ref><ref>https://www.elsevier.es/index.php?p=revista&pRevista=pdf-simple&pii=S2173509314700698</ref> | Shown below is an algorithm summarizing the treatment of [[adrenal insufficiency]]. <ref name="BornsteinAllolio2016">{{cite journal|last1=Bornstein|first1=Stefan R.|last2=Allolio|first2=Bruno|last3=Arlt|first3=Wiebke|last4=Barthel|first4=Andreas|last5=Don-Wauchope|first5=Andrew|last6=Hammer|first6=Gary D.|last7=Husebye|first7=Eystein S.|last8=Merke|first8=Deborah P.|last9=Murad|first9=M. Hassan|last10=Stratakis|first10=Constantine A.|last11=Torpy|first11=David J.|title=Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline|journal=The Journal of Clinical Endocrinology & Metabolism|volume=101|issue=2|year=2016|pages=364–389|issn=0021-972X|doi=10.1210/jc.2015-1710}}</ref><ref name="OpreaBonnet2019">{{cite journal|last1=Oprea|first1=Alina|last2=Bonnet|first2=Nicolas C. G.|last3=Pollé|first3=Olivier|last4=Lysy|first4=Philippe A.|title=Novel insights into glucocorticoid replacement therapy for pediatric and adult adrenal insufficiency|journal=Therapeutic Advances in Endocrinology and Metabolism|volume=10|year=2019|pages=204201881882129|issn=2042-0188|doi=10.1177/2042018818821294}}</ref><ref>https://www.elsevier.es/index.php?p=revista&pRevista=pdf-simple&pii=S2173509314700698</ref> | ||
{{familytree/start |summary= Adrenal insufficiency treatment Algorithm.}} | {{familytree/start |summary= Adrenal insufficiency treatment Algorithm.}} | ||
Line 71: | Line 71: | ||
{{familytree/end}} | {{familytree/end}} | ||
== | ==Dos== | ||
*In the diagnosis of [[Adrenal insufficiency]] plasma [[cortisol]] to be measured between 8:00-9:00 AM, after the early morning peak which happens between 6:00-8:00 AM. | *In the diagnosis of [[Adrenal insufficiency]] plasma [[cortisol]] to be measured between 8:00-9:00 AM, after the early morning peak which happens between 6:00-8:00 AM. | ||
*[[Hydrocortisone]] (preferred glucocorticoid) to be given in two or three divided doses to mimic the circadian rhythm. | *[[Hydrocortisone]] (preferred glucocorticoid) to be given in two or three divided doses to mimic the circadian rhythm. | ||
*[[Glucocorticoid]] dose to be titrated based on symptom improvement. The least possible dose of [[glucocorticoid]] has to be used. | *[[Glucocorticoid]] dose to be titrated based on symptom improvement. The least possible dose of [[glucocorticoid]] has to be used. | ||
*[[Mineralocorticoid]] dose to be titrated based on symptom improvement (salt craving, postural hypotension, edema) and electrolytes. | *[[Mineralocorticoid]] dose to be titrated based on symptom improvement (salt craving, postural hypotension, edema) and electrolytes. | ||
*After adjusting the dose follow up to be continued annually. | *After adjusting the dose, follow-up to be continued annually. | ||
*Patients | *Patients should be educated on how to self increase the dose of [[glucocorticoid]] in the presence of other illnesses like fever, wounds. | ||
*Patients | *Patients should be educated on carrying steroid emergency and medical alert identification in the event of [[adrenal crisis]] for early detection and treatment. | ||
*Patients | *Patients should be educated on carrying and injecting [[glucocorticoid]] in case of an emergency.<ref>https://www.elsevier.es/index.php?p=revista&pRevista=pdf-simple&pii=S2173509314700698</ref><ref name="BornsteinAllolio2016" /> | ||
==Don'ts== | ==Don'ts== | ||
*Insulin hypoglycemic test not be used in the diagnosis of [[adrenal insufficiency]] in patients age >60 Y, cardiovascular disease, hypertension, epilepsy and pregnancy. | *Insulin hypoglycemic test not be used in the diagnosis of [[adrenal insufficiency]] in patients age >60 Y, cardiovascular disease, hypertension, epilepsy and pregnancy. | ||
*[[Glucocorticoid]] replacement not to be given after 6 PM. | *[[Glucocorticoid]] replacement not to be given after 6 PM. | ||
*[[ACTH]] and Serum [[Cortisol]] levels not to be used for monitoring treatment efficacy. | *[[ACTH]] and Serum [[Cortisol]] levels not to be used for monitoring treatment efficacy. | ||
*In patients on [[fludrocortisone]] who develop [[hypertension]], the drug not be discontinued. Instead, first reduce the dose of [[fludrocortisone]]. If [[hypertension]] remains uncontrolled add anti hypertensive.<ref>https://www.elsevier.es/index.php?p=revista&pRevista=pdf-simple&pii=S2173509314700698</ref><ref name="BornsteinAllolio2016" /> | *In patients on [[fludrocortisone]] who develop [[hypertension]], the drug should not be discontinued. Instead, first reduce the dose of [[fludrocortisone]]. If [[hypertension]] remains uncontrolled, add anti hypertensive.<ref>https://www.elsevier.es/index.php?p=revista&pRevista=pdf-simple&pii=S2173509314700698</ref><ref name="BornsteinAllolio2016" /> | ||
==References== | ==References== | ||
Line 94: | Line 96: | ||
[[Category:Resident survival guide]] | [[Category:Resident survival guide]] | ||
[[Category:Templates]] | [[Category:Templates]] | ||
[[Category:Up-To-Date]] | |||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} |
Latest revision as of 17:07, 29 January 2021
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayeesha Kattubadi, M.B.B.S[2]
Overview
Adrenal insufficiency is a clinical state where there is reduced production of adrenocortical hormones. The adrenal cortex is divided into three zones- zona glomerulosa, zona fasciculata and zona reticularis producing mineralocorticoids, glucocorticoids and androgens respectively. Adrenal insufficiency can cause glucocorticoid and mineralocorticoid deficiency. It is classified as primary, secondary and tertiary. Its presentation depends on the rapidity and degree of hormone depletion. It can present acutely as adrenal crisis, especially when the body is under stress due infections, trauma etc. If it presents chronically, it is called Addison's disease. The common causes include chronic glucocorticoid use and autoimmune adrenalitis. It is diagnosed using serum basal cortisol measurement and ACTH stimulation test. Treatment consists of lifelong glucocorticoid and mineralocorticoid replacement. [1] [2]
Causes
Life-Threatening Causes
Life-threatening causes include conditions that may result in death or permanent disability within 24 hours if left untreated.[3]
Common Causes
Common causes of adrenal insufficiency may include:[4][5]
- Primary adrenal insufficiency: Autoimmune adrenalitis
- Central adrenal insufficiency: Chronic glucocorticoid use.
Less common causes:
- Infections:
- Tuberculosis
- Fungal infections(histoplasma)
- Cytomegalovirus
- HIV
- Adrenal hemorrhage
- X-linked adrenoleukodystrophy
- Trauma
- Metastasis
Diagnosis
Shown below is an algorithm summarizing the diagnosis of adrenal insufficiency.[5][6]
Adrenal Insufficiency suspected | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Serum basal cortisol | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
<5 µg/dL | 5-18 µg/dL | >18 µg/dL | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Confirms Adrenal Insufficiency | Dynamic tests | Rules out Adrenal Insufficiency | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Primary Adrenal Insufficiency suspected | Secondary Adrenal Insufficiency suspected | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ACTH stimulation test | ACTH stimulation test | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Serum cortisol <18 µg/dL | Serum cortisol >18µg/dL | Serum cortisol <18 µg/dL | Serum cortisol 18-23µg/dL | Serum cortisol >23 µg/dL | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Confirms Adrenal Insufficiency | Rules out Adrenal Insufficiency | Confirms Adrenal Insufficiency | Indeterminate | Rules out Adrenal Insufficiency | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Insulin hypoglycemic test | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Serum cortisol <18µg/dL | Serum cortisol >18µg/dL | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Confirms Adrenal Insufficiency | Rules out Adrenal Insufficiency | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Treatment
Shown below is an algorithm summarizing the treatment of adrenal insufficiency. [5][7][8]
Primary adrenal insufficiency | Secondary adrenal insufficiency | ||||||||||||||||||||||||||||||||||||||
Lifelong Glucocorticoid and Mineralocorticoid replacement therapy | Lifelong Glucocorticoid replacement therapy | ||||||||||||||||||||||||||||||||||||||
Mineralocorticoid replacement therapy: 9 α-Fludrocortisone 0.05-0.2 mg/day PO single dose in the morning | |||||||||||||||||||||||||||||||||||||||
Glucocorticoid replacement therapy: 1. Hydrocortisone 15-25mg PO in two or three divided doses 2. Cortisone acetate 20-25mg PO single dose in the morning | |||||||||||||||||||||||||||||||||||||||
Dos
- In the diagnosis of Adrenal insufficiency plasma cortisol to be measured between 8:00-9:00 AM, after the early morning peak which happens between 6:00-8:00 AM.
- Hydrocortisone (preferred glucocorticoid) to be given in two or three divided doses to mimic the circadian rhythm.
- Glucocorticoid dose to be titrated based on symptom improvement. The least possible dose of glucocorticoid has to be used.
- Mineralocorticoid dose to be titrated based on symptom improvement (salt craving, postural hypotension, edema) and electrolytes.
- After adjusting the dose, follow-up to be continued annually.
- Patients should be educated on how to self increase the dose of glucocorticoid in the presence of other illnesses like fever, wounds.
- Patients should be educated on carrying steroid emergency and medical alert identification in the event of adrenal crisis for early detection and treatment.
- Patients should be educated on carrying and injecting glucocorticoid in case of an emergency.[9][5]
Don'ts
- Insulin hypoglycemic test not be used in the diagnosis of adrenal insufficiency in patients age >60 Y, cardiovascular disease, hypertension, epilepsy and pregnancy.
- Glucocorticoid replacement not to be given after 6 PM.
- ACTH and Serum Cortisol levels not to be used for monitoring treatment efficacy.
- In patients on fludrocortisone who develop hypertension, the drug should not be discontinued. Instead, first reduce the dose of fludrocortisone. If hypertension remains uncontrolled, add anti hypertensive.[10][5]
References
- ↑ Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dungan K, Grossman A, Hershman JM, Hofland J, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Purnell J, Singer F, Stratakis CA, Trence DL, Wilson DP, Nicolaides NC, Chrousos GP, Charmandari E. PMID 25905309. Missing or empty
|title=
(help) - ↑ Huecker MR, Dominique E. PMID 28722862. Missing or empty
|title=
(help) - ↑ https://www.ncbi.nlm.nih.gov/books/NBK499968/
- ↑ Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dungan K; et al. (2000). "Endotext". PMID 25905309.
- ↑ 5.0 5.1 5.2 5.3 5.4 Bornstein, Stefan R.; Allolio, Bruno; Arlt, Wiebke; Barthel, Andreas; Don-Wauchope, Andrew; Hammer, Gary D.; Husebye, Eystein S.; Merke, Deborah P.; Murad, M. Hassan; Stratakis, Constantine A.; Torpy, David J. (2016). "Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline". The Journal of Clinical Endocrinology & Metabolism. 101 (2): 364–389. doi:10.1210/jc.2015-1710. ISSN 0021-972X.
- ↑ https://www.elsevier.es/index.php?p=revista&pRevista=pdf-simple&pii=S2173509314700698
- ↑ Oprea, Alina; Bonnet, Nicolas C. G.; Pollé, Olivier; Lysy, Philippe A. (2019). "Novel insights into glucocorticoid replacement therapy for pediatric and adult adrenal insufficiency". Therapeutic Advances in Endocrinology and Metabolism. 10: 204201881882129. doi:10.1177/2042018818821294. ISSN 2042-0188.
- ↑ https://www.elsevier.es/index.php?p=revista&pRevista=pdf-simple&pii=S2173509314700698
- ↑ https://www.elsevier.es/index.php?p=revista&pRevista=pdf-simple&pii=S2173509314700698
- ↑ https://www.elsevier.es/index.php?p=revista&pRevista=pdf-simple&pii=S2173509314700698